[Primary ileocecal lymphoma: report of 30 cases].
To investigate the best therapeutic method for primary ileocecal non-Hodgkin's lymphoma. Clinicopathologic features of 30 patients who had been treated from June 1964 to September 1993 were analyzed retrospectively. Twenty-eight patients (93%) underwent resection of their disease. Eleven patients had the resection followed by chemotherapy. Eleven patients had the resection followed by chemotherapy and radiotherapy. All had pathologic evidence. Twenty-nine patients were categorized as B-cell type NHL. One had T-cell lesion. Eleven patients had stage I disease, 11 stage II, 4 stage III, and 4 stage IV. The 5-year survival rate was 36.67%. The prognostic factors are stage of the disease and treatment modality. Adequate initial surgery combined with radiotherapy and chemotherapy may provide optimum therapy for patients with primary ileocecal lymphoma.